Back to Discover

Replimune Group, Inc.

REPL · Biotech · Nasdaq · As of 10 Sep 2026
60AIR SCORE
  • FundamentalsNot enough data yet
  • ValueNot enough data yet
  • News flowBalanced
  • MomentumVery strong
  • SafetyBalanced

Overall confidence 41/100 — few inputs available yet

Fundamental score not available. AIR's fundamental engine is built for businesses with established revenue and cash flow; biotech financial profiles — often R&D-heavy or pre-revenue — don't yet fit the measures it requires. AIR still assesses this company on discovery, market confirmation and risk, at reduced overall confidence.

Discovery Gap: Medium (23/100) · Gap confidence 52/100Some evidence isn't yet fully priced in.

This month at a glance

AIR Score™ change: 0AIR Score™ held steady this month.
Cycle window9 Sep 202610 Sep 2026
MoversNothing moved meaningfully this month.

Evidence timeline

  1. [8-K 2.02] Replimune Group, Inc. — Results of Operations and Financial ConditionSEC · SEC EDGAR
    Aug 14, 2026 · FORM 8-K
  2. [8-K/A 8.01] Replimune Group, Inc. — Other EventsSEC · SEC EDGAR
    Aug 9, 2026 · FORM 8-K/A
  3. [8-K 8.01] Replimune Group, Inc. — Other EventsSEC · SEC EDGAR
    Aug 9, 2026 · FORM 8-K
  4. [8-K 8.01] Replimune Group, Inc. — Other EventsSEC · SEC EDGAR
    Aug 6, 2026 · FORM 8-K
  5. [8-K 8.01] Replimune Group, Inc. — Other EventsSEC · SEC EDGAR
    Jul 30, 2026 · FORM 8-K
  6. [8-K 2.02] Replimune Group, Inc. — Results of Operations and Financial ConditionSEC · SEC EDGAR
    Jun 29, 2026 · FORM 8-K
  7. [8-K 8.01] Replimune Group, Inc. — Other EventsSEC · SEC EDGAR
    Apr 10, 2026 · FORM 8-K
  8. [8-K 2.02] Replimune Group, Inc. — Results of Operations and Financial ConditionSEC · SEC EDGAR
    Feb 3, 2026 · FORM 8-K
  9. [8-K 1.01] Replimune Group, Inc. — Entry into a Material Definitive AgreementSEC · SEC EDGAR
    Feb 3, 2026 · FORM 8-K
  10. [8-K 2.03] Replimune Group, Inc. — Creation of a Material Direct Financial ObligationSEC · SEC EDGAR
    Feb 3, 2026 · FORM 8-K
  11. [8-K 2.02] Replimune Group, Inc. — Results of Operations and Financial ConditionSEC · SEC EDGAR
    Nov 6, 2025 · FORM 8-K
  12. [8-K 8.01] Replimune Group, Inc. — Other EventsSEC · SEC EDGAR
    Oct 20, 2025 · FORM 8-K

Ask AIR

What would change our view

A weaker balance sheet in the next filing cycle, a material regulatory setback, or a new evidence cluster that re-opens a distance between filings and attention would move the score, and the page would show which one did.

Research, not tips. No buy/sell recommendations, no price forecasts. Every score is derived from public filings and market data — figures round to whole numbers and refresh each trading day.

REPL — Replimune Group, Inc. · AIR Discovery Research